News

Business Wire5h
Elegen and Nutcracker Therapeutics to Pilot First Fully Cell-Free Manufacturing Process for RNA-based Personalized Cancer Therapeutics
Fully cell-free process aims to democratize personalized cancer therapeutics with shorter turnaround and negligible bioburden ...